Concepedia

A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence

Robert A. Schnoll, Frank T. Leone, Anna Veluz‐Wilkins, Andrew Miele, Anita Hole, Nancy C. Jao, E. Paul Wileyto, Allison J. Carroll, Ravi Kalhan, Jyoti D. Patel,

Psycho-Oncology · 2019 · 38 citations · 30 references

DOIFull text

Open access

Abstract

Compared with ST, ET varenicline does not increase patient risk and increases smoking cessation rates among patients who adhere to treatment. Studies are needed to identify effective methods to increase medication adherence to treat patient tobacco use effectively.

References

30

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

David V. Sheehan · The Journal of Clinical Psychiatry · 1998 · 19.4K citations

, , +8

The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire

Todd F. Heatherton, Lynn T. Kozlowski, Richard C. Frecker et al. · British Journal of Addiction · 1991 · 10.6K citations

, , +17

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

David V. Sheehan, Y. Lecrubier, Sheehan Kh et al. · PubMed · 1998 · 10.3K citations

Biochemical verification of tobacco use and cessation

Neal L. Benowitz, Peyton Jacob, Karen Ahijevych et al. · Nicotine & Tobacco Research · 2002 · 1.8K citations · Full text

, , +3

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

Robert M. Anthenelli, Neal L. Benowitz, Robert West et al. · The Lancet · 2016 · 1.1K citations

, , +15